Table 5.
Oncological outcomes for recurrence
| Variable | Surgery alonea (n = 65) | Bridge to surgery (n = 43) | HR (95% CI)b | P-value |
|---|---|---|---|---|
| Any recurrences | 10 (15.4) | 12 (27.9) | 2.22 (0.95−5.19) | 0.066 |
| Locoregional recurrences | 6 (9.2) | 3 (7.0) | 1.05 (0.26−4.29) | 0.948 |
| Anastomotic | 0 (0) | 1 (2.3) | ||
| Peritoneum | 5 (7.7) | 3 (7.0) | ||
| Pelvic lymph node | 1 (1.5) | 0 (0) | ||
| Distant metastatic recurrences | 7 (10.8) | 11 (25.6) | 2.67 (1.03−6.91) | 0.043c |
| Liver | 1 (1.5) | 6 (14.0) | ||
| Lung | 3 (4.6) | 3 (7.0) | ||
| Para-aortic lymph node | 2 (3.1) | 1 (2.3) | ||
| Ovary | 1 (1.5) | 1 (2.3) |
HR, hazard ratio; CI, confidence interval.
a
Reference group.
b
Values were determined by Cox proportional hazards model analysis.
c
Statistically significant.